International Flavors & Fragrances Health & Biosciences — Depreciation Expense, Add-Back remained flat by 0.0% to -$32.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.3%, from -$29.00M to -$32.00M. Over 3 years (FY 2022 to FY 2025), Health & Biosciences — Depreciation Expense, Add-Back shows a downward trend with a 6.0% CAGR.
High depreciation relative to capital expenditures may suggest an aging asset base requiring future investment.
The non-cash expense allocated to the wear and tear of tangible assets used by the Health & Biosciences segment, which i...
Standard depreciation add-back found in segment-level EBITDA reconciliations.
iff_segment_health_biosciences_depreciation_expense_add_back| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$26.00M | -$26.00M | -$26.00M | -$26.00M | -$28.25M | -$28.25M | -$28.25M | -$28.25M | -$29.00M | -$28.00M | -$29.00M | -$29.00M | -$29.00M | -$31.00M | -$32.00M | -$32.00M | -$32.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -8.7% | +0.0% | +0.0% | +0.0% | -2.7% | +3.4% | -3.6% | +0.0% | +0.0% | -6.9% | -3.2% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -8.7% | -8.7% | -8.7% | -8.7% | -2.7% | +0.9% | -2.7% | -2.7% | +0.0% | -10.7% | -10.3% | -10.3% | -10.3% |